2025-04-09 - Analysis Report
## Honeywell International Inc. (HON) Stock Review

**0. Key Figures at a Glance:**

* **Cumulative Return (HON):** 24.27%
* **Cumulative Return (VOO):** 55.14%
* **Return Difference:** -30.9%
* **Relative Divergence:** 19.1% (This indicates HON's underperformance relative to VOO is in the 19.1st percentile of historical divergence between the two.)
* **Current Price:** $186.75
* **RSI:** 25.47 (Suggests oversold conditions)
* **PPO:** -1.07 (Indicates bearish momentum)
* **Market Risk Indicator (MRI):** 0.4883 (High Risk)


**1. Performance Comparison and Company Overview:**

Honeywell International Inc. (HON) is a diversified technology and manufacturing company.  Over the period analyzed, HON significantly underperformed the S&P 500 (VOO), with a cumulative return of 24.27% compared to VOO's 55.14%. The difference of -30.9% places HON's performance in the 19.1st percentile of historical underperformance relative to VOO based on the provided data.

**Alpha and Beta Analysis:**

The provided data shows varying alpha and beta values across different periods.  Alpha generally indicates outperformance (positive) or underperformance (negative) relative to the market (beta=1), while beta shows the volatility relative to the market. While some periods show positive alpha,  recent years (2021-2025) display negative alphas and increasingly high betas, suggesting greater volatility and underperformance relative to the market. The high beta in recent periods amplifies the market's negative movements.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 37.0% | 56.3% | 8.0% | 0.1 | 82.4 |
| 2016-2018  | 24.0% | 63.2% | 6.0% | 0.1 | 75.5 |
| 2017-2019  | 43.0% | 63.2% | 14.0% | 0.5 | 103.3 |
| 2018-2020  | 51.0% | 63.2% | 26.0% | 0.4 | 127.0 |
| 2019-2021  | 49.0% | 59.5% | -6.0% | 0.5 | 126.6 |
| 2020-2022  | 34.0% | 71.1% | 28.0% | 0.5 | 132.8 |
| 2021-2023  | -10.0% | 71.1% | -27.0% | 0.7 | 132.9 |
| 2022-2024  | -21.0% | 71.6% | -38.0% | 0.7 | 146.2 |
| 2023-2025  | -46.0% | 71.6% | -49.0% | 1.0 | 121.5 |


**2. Recent Price Movement:**

* **Closing Price:** $186.75
* **Last Market Price:** $186.915 (a slight decrease of -$0.29 from the previous close)
* **5-Day Moving Average:** $202.77
* **20-Day Moving Average:** $208.41
* **60-Day Moving Average:** $212.39

The current price is significantly below all three moving averages, suggesting a downtrend.


**3. Technical Indicators and Expected Return:**

* **RSI:** 25.47 (oversold territory, indicating potential for a bounce but not confirming an uptrend)
* **PPO:** -1.07 (negative value confirms bearish momentum)
* **20-Day Relative Divergence Change:** +1.1 (Short-term upward movement, but needs confirmation)
* **Market Risk Indicator (MRI):** 0.4883 (High Risk)
* **Expected Return (2+ years):** -4.1%  (This suggests underperformance relative to the S&P 500 even over the long term, based on current trends).  The recent price drop of -$0.29 adds to the negative outlook.


**4. Recent Earnings Analysis:**

The earnings data shows some fluctuation in EPS and revenue.  There's no clear upward or downward trend visible in this short period. Further analysis is needed to determine the overall trend. Note there is a duplicate entry for 2024-10-24.

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-24 | 2.17 | $9.73B        |
| 2024-07-25 | 2.37 | $9.58B        |
| 2024-04-25 | 2.24 | $9.11B        |
| 2023-10-26 | 2.29 | $9.21B        |
| 2024-10-24 | 2.29 | $9.21B        |


**5. Financial Information:**

Revenue has been relatively stable in recent quarters, hovering around $9.5B-$10B. Profit margins are consistently high (above 34%), suggesting good profitability.  Equity is steadily increasing, and ROE shows some fluctuation but remains generally positive, indicating a reasonable return on investment.


| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2024-12-31 | $10.09B    | 36.38%        |
| 2024-09-30 | $9.73B     | 38.54%        |
| 2024-06-30 | $9.58B     | 38.85%        |
| 2024-03-31 | $9.11B     | 38.68%        |
| 2023-12-31 | $9.44B     | 34.31%        |

| Quarter    | Equity     | ROE  |
|------------|------------|------|
| 2024-12-31 | $18.62B    | 6.90% |
| 2024-09-30 | $17.41B    | 8.12% |
| 2024-06-30 | $16.95B    | 9.11% |
| 2024-03-31 | $16.45B    | 8.89% |
| 2023-12-31 | $15.86B    | 7.97% |


**6. Overall Analysis:**

HON currently shows signs of underperformance compared to the S&P 500.  Technical indicators suggest oversold conditions and bearish momentum.  While the financial statements display strong profitability and increasing equity, the recent negative alpha and high beta values signal significant market risk and underperformance relative to the broader market.  The negative expected return over the long term further reinforces this cautionary outlook.  A deeper dive into the reasons behind the recent underperformance, including sector-specific factors and any company-specific news, would be necessary before making any investment decisions.  Given the high-risk indicator and negative expected return, further investigation is recommended before considering any investment in HON at this time.
